Smokeless Tobacco Rates on the Rise

Source: WebMD By: Bill Hendrick Even after a generation of warnings from public health officials about the dangers of tobacco use, about 20% of Americans still smoke cigarettes, a CDC report says. The report also shows the rate of smokers who also use smokeless tobacco, such as chewing tobacco and snuff, is rising. Using smokeless tobacco can keep the nicotine habit alive, making it even harder to quit than going cold turkey, Terry Pechacek, PhD, of the CDC, tells WebMD. More Americans are turning to smokeless tobacco because of laws that prohibit smoking in public places such as bars, restaurants, and airplanes -- and also because smokeless forms can be used in offices and on the job, Pechacek says. Immediate Benefits of Smoking Cessation The tobacco companies market smokeless tobacco as a substitute for smokers, but they don’t help people quit smoking, Pechacek tells WebMD. “We are making no progress in getting people to quit smoking,” he says. “This is a tragedy. Over 400,000 people are dying prematurely and won’t be able to walk their children down the aisle or see their grandchildren.” Contrary to common beliefs of smokers, the benefits of quitting start immediately, Pechacek tells WebMD. “We see lower rates for heart attacks within months of quitting,” he says. “And lower rates for lung cancer, too. Stopping a decline in lung function is one of the biggest benefits of quitting smoking.” The national smoking prevalence rate was 20.6% in 2008 and 2009. About 23% of males smoke, compared [...]

2010-11-22T12:24:26-07:00November, 2010|Oral Cancer News|

The Most Deadly HPVs in the World

Source: WebMD News Author: Daniel DeNoon Cervical Cancer-Causing Viruses ID'd in Worldwide Study Oct. 19, 2010 – Two human papillomavirus types included in HPV vaccines cause 71% of cervical cancers -- but there are six other cervical cancer-causing HPVs, an international study finds. Led by Spanish researcher Silvia de Sanjose, MD, the effort analyzed 22,661 tissue samples from 14,249 women from 38 countries in six continents. Researchers looked for any of the 118 known types of HPV. The samples included 10,575 cases of invasive cervical cancer -- for women, the second most common cancer in the world. HPV is believed to cause nearly all cervical cancers. Although the study detected HPV in only 85% of cervical cancers, de Sanjose and colleagues suggest that various problems (such as DNA degradation in samples) led researchers to miss HPV in the remaining 15% of cases. There are currently two HPV vaccines: Cervarix from GlaxoSmithKline and Gardasil from Merck. Both protect against HPV types 16 and 18; Gardasil also protects against the genital wart-causing HPV strains 6 and 11. The new study strongly supports use of these vaccines, as HPV 16 and HPV 18 account for 71% of invasive cervical cancers. HPV 16, HPV 18, and HPV 45 are found in 94% of cervical adenocarcinomas. HPV types 18 and 45 are found in much younger women with invasive cervical cancer, suggesting that these viruses are particularly deadly. HPV 16 is also linked to cancer in younger women. In addition to HPV 16, 18, and [...]

2010-10-26T12:24:24-07:00October, 2010|Oral Cancer News|
Go to Top